FK 506 therapy for refractory renal allograft rejection: Lessons from liver transplantation

Clinical Transplantation

Volumn 10, Issue 4, 1996, Pages 323-332

  Woodle, E Steve ^a   Bruce, David S ^a   Josephson, Michelle ^a   Newell, Kenneth A ^a   Piper, James B ^a   Michael Millis, J ^a   Cronin, David ^a   Whitman, Greg ^a   Ruebe, Margaret ^a   Thistlethwaite Jr , J Richard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

FK 506; Kidney transplant; Rejection; Tacrolimus

Indexed keywords

CREATININE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; RECURRENCE; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029759852     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. MAYES JT, THISTLETHWAITE JR. STUART JK, BUCKINGHAM MR, STUART FP. Re-exposure to OKT3 in renal allograft recipients. Transplantation 1988: 45: 349.
2. NORMAN DJ, SHIELD CF, HENELL KR, et al. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection. Transplantation 1988: 46: 523.
3. FIRST ME, SCHROEDER TJ, BURTUBISE PE, et al. Successful retreatment of allograft rejection with OKT3. Transplantation 1989; 47: 88.
4. SCHREIBER SL, CrABTREE GR. The mechanism of action of cyclosporin A and FK 506. Immunol Today 1992: 13: 136.
5. SCHREIBER SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991: 251: 283.
6. U.S. MULTICENTEr FK 506 LIVER STUDY GROUP. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331: 1110.
7. EUROPEAN FK 506 MULTICENTER LIVER STUDY GROUP. Randomised trial comparing tacrolius (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994: 344: 423.
8. WOODLE ES, PERDRIZET GA, SO SKS, WHITE HM, MARSH JW. FK 506 rescue therapy for hepatic allograft rejection: Experience with an aggressive approach. Clin Transpl 1995 9: 45.
9. US MULTICENTER FK 506 LIVER STUDY GROUP. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. Transplant Proc 1993: 25: 635.
10. US MULTICENTER FK 506 LIVER STUDY GROUP. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. Transplant Proc 1993: 25: 641.
11. US MULTICENTER FK 506 LIVER STUDY GROUP. Use of FK 506 as rescue therapy for refractory rejection after liver transplantation. Transplant Proc 1993: 25: 679.
12. STARZL TE, FUNG JJ, JORDAN M, et al. Kidney transplantation under FK-506. J Am Med Assoc1990: 264: 63.
13. SHAPIRO R. JORDAN M, FUNG JJ, et al. Kidney transplantation under FK-506 immunosuppression. Transplantation Proc 1991: 23(1): 920.
14. SHAPIRO R. JORDAN M, SCANTLEBURY V, et al. FK-506 in clinical kidney transplantation. Transplantation 1991: 23 (6): 3065.
15. JAPANESE FK-506 STUDY GROUP. Japanese study of FK-506 on kidney transplantation: Results of an early phase II study. Transplantation Proc 1991: 23(6): 3071.
16. JAPANESE FK-506 STUDY GROUP. Japanese study of FK-506 on kidney transplantation: Results of late phase 11 study. Transplantation Proc 1993: 25(1): 649-654.
17. SHAPIRO R. JORDAN M, SCANTLEBURY V et al. A prospective, randomized trial of FK-506 in renal transplantation - A comparison between double-and triple-drug therapy. Clin Transpl 1994: 8: 508.
18. JORDAN ML, SHAPIRO R. JENSEN CWB et al. FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc 1991: 23: 3078.
19. JORDAN ML. SHAPIRO R. VIVAS CA et al. FK 506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994: 57: 860.
20. RUCAY P. SAMUEL D, GILLET D, BISMUTH H. FK 506 rescue therapy for refractory acute rejection in five liver recipients. Transplant Proc 1991: 23: 3000.
21. SHAW BW, MARLAN R. STRATTA R et al. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. Transplant Proc 1991: 23: 2994.
22. FRANK B. PERDRIZET GA, WHITE HM et al. Neurotoxicity of FK 506 in liver transplant recipients. Transplant Proc 1993: 25: 1887.
23. MUELLER AR, PLATZ KP, BECHSTEIN WO et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 1994: 58: 155.